Efecto antiproteinúrico del bloqueo del sistema renina-angiotensina-aldosterona (SRAA) en los pacientes obesos. ¿Cuál es la opción terapéutica más eficaz?
The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective?
Leído
21755
Vecesse ha leído el artículo
2921
Total PDF
18834
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 75 | 9 | 84 |
| 2025 5 | 380 | 37 | 417 |
| 2025 4 | 362 | 27 | 389 |
| 2025 3 | 342 | 53 | 395 |
| 2025 2 | 350 | 47 | 397 |
| 2025 1 | 350 | 33 | 383 |
| 2024 12 | 281 | 36 | 317 |
| 2024 11 | 241 | 49 | 290 |
| 2024 10 | 321 | 46 | 367 |
| 2024 9 | 244 | 39 | 283 |
| 2024 8 | 217 | 73 | 290 |
| 2024 7 | 197 | 32 | 229 |
| 2024 6 | 201 | 44 | 245 |
| 2024 5 | 234 | 42 | 276 |
| 2024 4 | 177 | 44 | 221 |
| 2024 3 | 131 | 27 | 158 |
| 2024 2 | 143 | 39 | 182 |
| 2024 1 | 142 | 23 | 165 |
| 2023 12 | 139 | 31 | 170 |
| 2023 11 | 176 | 45 | 221 |
| 2023 10 | 162 | 29 | 191 |
| 2023 9 | 176 | 30 | 206 |
| 2023 8 | 135 | 18 | 153 |
| 2023 7 | 180 | 26 | 206 |
| 2023 6 | 153 | 31 | 184 |
| 2023 5 | 212 | 35 | 247 |
| 2023 4 | 132 | 35 | 167 |
| 2023 3 | 175 | 33 | 208 |
| 2023 2 | 144 | 33 | 177 |
| 2022 1 | 144 | 35 | 179 |
| 2022 12 | 90 | 28 | 118 |
| 2022 11 | 159 | 35 | 194 |
| 2022 10 | 173 | 44 | 217 |
| 2022 9 | 103 | 30 | 133 |
| 2022 8 | 160 | 54 | 214 |
| 2022 7 | 156 | 42 | 198 |
| 2022 6 | 119 | 32 | 151 |
| 2022 5 | 163 | 40 | 203 |
| 2022 4 | 180 | 54 | 234 |
| 2022 3 | 129 | 60 | 189 |
| 2022 2 | 168 | 44 | 212 |
| 2021 1 | 166 | 35 | 201 |
| 2021 12 | 123 | 42 | 165 |
| 2021 11 | 171 | 48 | 219 |
| 2021 10 | 124 | 51 | 175 |
| 2021 9 | 116 | 34 | 150 |
| 2021 8 | 108 | 42 | 150 |
| 2021 7 | 140 | 41 | 181 |
| 2021 6 | 131 | 25 | 156 |
| 2021 5 | 110 | 41 | 151 |
| 2021 4 | 177 | 53 | 230 |
| 2021 3 | 140 | 28 | 168 |
| 2021 2 | 154 | 34 | 188 |
| 2020 1 | 104 | 29 | 133 |
| 2020 12 | 135 | 14 | 149 |
| 2020 11 | 120 | 21 | 141 |
| 2020 10 | 135 | 16 | 151 |
| 2020 9 | 97 | 16 | 113 |
| 2020 8 | 77 | 18 | 95 |
| 2020 7 | 87 | 14 | 101 |
| 2020 6 | 113 | 14 | 127 |
| 2020 5 | 107 | 12 | 119 |
| 2020 4 | 133 | 31 | 164 |
| 2020 3 | 89 | 12 | 101 |
| 2020 2 | 124 | 28 | 152 |
| 2020 1 | 108 | 30 | 138 |
| 2019 12 | 79 | 15 | 94 |
| 2019 11 | 110 | 27 | 137 |
| 2019 10 | 114 | 16 | 130 |
| 2019 9 | 94 | 16 | 110 |
| 2019 8 | 65 | 22 | 87 |
| 2019 7 | 86 | 26 | 112 |
| 2019 6 | 92 | 17 | 109 |
| 2019 5 | 103 | 16 | 119 |
| 2019 4 | 146 | 41 | 187 |
| 2019 3 | 65 | 21 | 86 |
| 2019 2 | 44 | 21 | 65 |
| 2019 1 | 55 | 15 | 70 |
| 2018 12 | 117 | 32 | 149 |
| 2018 11 | 143 | 15 | 158 |
| 2018 10 | 108 | 21 | 129 |
| 2018 9 | 88 | 12 | 100 |
| 2018 8 | 66 | 17 | 83 |
| 2018 7 | 80 | 13 | 93 |
| 2018 6 | 66 | 12 | 78 |
| 2018 5 | 104 | 11 | 115 |
| 2018 4 | 90 | 14 | 104 |
| 2018 3 | 67 | 17 | 84 |
| 2018 2 | 64 | 10 | 74 |
| 2018 1 | 57 | 7 | 64 |
| 2017 12 | 69 | 10 | 79 |
| 2017 11 | 68 | 8 | 76 |
| 2017 10 | 72 | 8 | 80 |
| 2017 9 | 65 | 7 | 72 |
| 2017 8 | 62 | 7 | 69 |
| 2017 7 | 61 | 11 | 72 |
| 2017 6 | 78 | 10 | 88 |
| 2017 5 | 68 | 10 | 78 |
| 2017 4 | 63 | 9 | 72 |
| 2017 3 | 53 | 24 | 77 |
| 2017 2 | 91 | 19 | 110 |
| 2016 1 | 46 | 7 | 53 |
| 2016 12 | 102 | 38 | 140 |
| 2016 11 | 153 | 10 | 163 |
| 2016 10 | 131 | 12 | 143 |
| 2016 9 | 156 | 16 | 172 |
| 2016 8 | 258 | 4 | 262 |
| 2016 7 | 193 | 4 | 197 |
| 2016 6 | 108 | 0 | 108 |
| 2016 5 | 149 | 0 | 149 |
| 2016 4 | 112 | 0 | 112 |
| 2016 3 | 93 | 0 | 93 |
| 2016 2 | 143 | 0 | 143 |
| 2015 1 | 136 | 0 | 136 |
| 2015 12 | 154 | 0 | 154 |
| 2015 11 | 109 | 0 | 109 |
| 2015 10 | 117 | 0 | 117 |
| 2015 9 | 80 | 0 | 80 |
| 2015 8 | 77 | 0 | 77 |
| 2015 7 | 76 | 0 | 76 |
| 2015 6 | 75 | 0 | 75 |
| 2015 5 | 95 | 0 | 95 |
| 2015 4 | 42 | 0 | 42 |
| 2015 2 | 2371 | 0 | 2371 |
Mostrar todo
